Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of naltrexone on positive and negative symptoms in schizophrenia
IRCT201110093010N4Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of naltrexone in schizophrenia, sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Change in positive symptoms of schizophrenia and Change in negative symptoms of schizophrenia. Started Mar 2012; status: completed.
02
Drugs
naltrexone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT201110093010N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201110093010N4.